
--- Page 1 ---
1cs-0 -3 Carcnoma,mfjl+rntwg ouct, N0S 8500|3 1/8/10 lw Sir wdu: bruast, Nos  c50.9 TSS: SPECIMENS: UUID:1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4 TCGA-E2-A15D-01A-PR Redacted A. RIGHT BREAST CANCER B. SENTINEL L.N. #1 RIGHT AXILLA C. SENTINEL L.N. #2 RIGHT AXIL;LA D. SENTINEL L.N. #3 RIGHT AXILLA E. SENTINEL L.N. #4 RIGHT AXILLA SPECIMEN(S): A. RIGHT BREAST CANCER B. SENTINEL L.N. #1 RIGHT AXILLA C. SENTINEL L.N. #2 RIGHT AXIL;LA D. SENTINEL L.N. #3 RIGHT AXILLA E. SENTINEL L.N. #4 RIGHT AXILLA GROSS DESCRIPTION: A. RIGHT BREAST CANCER Received fresh labeled with the patient's identification and "right breast needle localization" is a previously inked 53g. 6 x 5 x 4cm needle iocalized lumpectomy with radiograph. Ink code: anterior-yellow, posterior-black, superior-blue,. inferior-orange, medial-green, lateral-red. Specimen is serially sectioned from lateral to medial into 8 slices revealing a 2.5 x 2.3 x 1.5cm tan white firm well circumscribed mass, 0.6cm from the closest inferior margin in slices 2-7. A surgical clip is identified in slice 5. A portion of the specimen is submitted for tissue procurement. Representatively submitted: A1-A2: lateral margin slice 1 A3-A5: slice 2 A6-A8: slice 3 A9-A15: slice 4 A16: slice 5 with clip ID A17-A18: slice 6 A19-A20: slice 7 A21: medial margin. B. SENTINEL L.N. #1 RIGHT AXILLA Received fresh is a tan pink lymph node 1.2 x 1 x 1cm. The specimen is sectioned and a touch prep is taken. Toto B1. C. SENTINEL L.N. #2 RIGHT AXILLA Received fresh is a tan pink lymph node 0.8 x 0.6 x 0.5cm. The specimen is bisected and a touch prep is taken. Toto. C1. D. SENTINEL L.N. #3 RIGHT AXILLA  Received fresh is a tan pink lymph node 1.2 x 1 x 0.8cm. The specimen is bisected and a touch prep is taken. Toto. D1. E. SENTINEL L.N. #4 RIGHT AXILLA  Received fresh is a tan pink lymph node 1.4 x 1 x 0.6cm. The specimen is bisected and a touch prep is taken. Toto. E1. DIAGNOSIS: A. BREAST, RIGHT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 1, MEASURING 2.2-CM - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, CRIBRIFORM TYPE WITH CENTRAL NECROSIS - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR  - DCIS PRESENT WITHIN 0.15-CM FROM INFERIOR SURGICAL RESECTION MARGIN  - BIOPSY SITE CHANGES WITH FIBROSIS AND GRANULATION TISSUE - SEE SYNOPTIC REPORT. B. LYMPH NODE, SENTINEL #1, RIGHT AXILLA, EXCISION:E - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, SENTINEL #2, RIGHT AXILLA, EXCISION:E - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1) D. LYMPH NODE, SENTINEL #3, RIGHT AXILLA, EXCISION:E - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). E. LYMPH NODE, SENTINEL #4, RIGHT AXILLA, EXCISION:E

--- Page 2 ---
- ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1) SYNOPTIC REPORT - BREAST Specimen Type: Excision Needle Localization: Yes - For mass Laterality: (Right Invasive Tumor: Present Multifocality:No WHO CLASSIFICATION invasive ductal carcinoma, NOS 8500/3 Tumor size: 2.2cm Tumor Site: Not specified Margins: Negative Distance from closest margin: 0.4cm inferior Tubular Score: 2 Nuclear Grade: 2 Mitotic Score: 1 Modified Scarff Bloom Richardson Grade:e Necrosis: Absent Vascular/Lymphatic Invasion: None identified Lobular neoplasia:  None Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/4 DCIS present  Margins uninvolved by DCis 0.15-cm from inferior DCIS Quantity:Estimate 30% DCIS Type: Cribriform DCIS Location:Associated with invasive tumor Nuclear grade: Intermediate Necrosis: Present ER/PR/HER2 Results ER: Positive PR: Positive HER2: Negative by FISH Performed on Case: Pathological staging (pTN): pT 2 N O CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. INTRAOPERATIVE CONSULTATION: A. GROss v^MINATiON: Right breast- mass is 2.5cm and 0.6cm from the closest inferior margin. Diagnosis called to Dr. at  by Dr. TPB-TPC-TPD-TPE: SLN #1-4: Negative for carcinoma. Diagnosis called to Dr. at by Dr. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY RESULTS: Recurrence Score: 17 CLINICAL EXPERIENCE: Patients with a recurrence score of: 17 in the clinical validation study had an average rate of Distant Recurrence at 10 years of 11% ER Score: 9.8  Positive PR Score: 8.4 Positive Her2 Score: 9.5 Negative Interpretation: ER Negative < 6.5 Positive >= 6.5 PR Negative < 5.5 Positive >= 5.5

--- Page 3 ---
Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4 See separate report for further information. Test performed at:. Gross Dictation:e  Microscopic/Diagnostic Dictation: Pathoioaist. Final Review: Patholaxiet. Final: Pathologist,. Addendum: Pathologist, Addendum Final: Pathologist,.